Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 27, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Myocardial injury in severe COVID 19 as compared to non-COVID ARDS

Novartis Life Science Safety Writer Recruitment | Apply Online

PGIMER Life Science Job With Rs. 55,000 pm Salary | Scientist (Non-Medical)

Myocardial injury in severe COVID 19 as compared to non-COVID ARDS
  • BiotechToday
  • World

Myocardial injury in severe COVID 19 as compared to non-COVID ARDS

bioxone November 20, 2020November 20, 2020

Rohit Bhattacharjee, Amity University Kolkata

Cardiac troponin elevations in COVID 19 are common in myocardial injuries, also proposed as a prognostic factor. Important knowledge gaps remain in comprehending the clinical implications and epidemiology of myocardial injury. It is also not clear whether the incidence of myocardial injury in COVID-19 patients is higher than that observed in ARDS (Acute Respiratory Distress Syndrome). ARDS is the most common cause of hypoxemic respiratory failure manifesting into acute hypoxemia.

The goal was to determine the outcomes and objectives of myocardial injury in COVID-19 patients as compared to non-COVID ARDS. Troponin levels were assessed between the COVID-19 patients and the ones from a cohort study of myocardial injury in ARDS. Linear regression was performed to identify clinical factors with myocardial injuries in COVID-19. It was found that chronic kidney disease, lactate, fibrinogen, and ferritin was associated with myocardial injury. COVID-19 patients were older having high creatinine and low vital signs as compared to non-COVID ARDS. After certain adjustments, it was observed that COVID-19 patients had lower odds of myocardial injury as compared to non-COVID ARDS. Myocardial injury in severe COVID-19 is a function of baseline comorbidities, advanced age, and multisystem organ dysfunction like traditional ARDS and the adverse prognosis of myocardial injury in COVID-19 relates largely to multisystem organ involvement and critical illness.

Also read: COVID-19 infection in a pregnant woman with liver cytolysis

Source:- 

  1. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050543
  2. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I and Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis. Am J Emerg Med. 2020. doi: 10.1016/j.ajem.2020.04.052.
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged COVID-19; troponin; myocardial injury; ARDS creatinine Epidemiology hypoxemia multisystem organ dysfunction respiratory failure

One thought on “Myocardial injury in severe COVID 19 as compared to non-COVID ARDS”

  1. Pingback: Dirty toilet seats can transmit STDs - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

PGIMER Life Science Job With Rs. 55,000 pm Salary | Scientist (Non-Medical)

bioxone November 21, 2020

-Shristi Sharma, Team bioXone  PGIMER Scientist Job With Rs. 55,000 pm Salary – Apply Online. PGIMER Jobs. PGIMER Recruitment. Life Sciences MSc/PhD Apply. Interested and eligible applicants can check out all of the details on the same below: View Notification  VACANCY DEPARTMENT OF PEDIATRICS, PGIMER, CHANDIGARH Name of the Post: Scientist C (Non-medical) No. of […]

Related Post

  • BiotechToday
  • FEATURED
  • Latest
  • World

Transient modulation of the immune system with CRISPR-Cas 9 technology

bioxone September 8, 2020September 8, 2020

-Anwita Sarkar, Team bioXone The current scenario of the devastating global pandemic of COVID-19 clearly depicts the importance of our immune system for our survival. The vast network of cells and tissues of the immune system are constantly searching for foreign particles and are eliciting immune responses by modulating their genome. Thus, regulation of the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Borgs: Giant Extrachromosomal Elements found in mud Archaea

bioxone August 4, 2021August 3, 2021

Supriyo Mukherjee, Kalyani Mahavidyalaya Scientific researches have unveiled a novel conformation of gigantic, extrachromosomal DNA in mud-dwelling archaea, as stated in a preprint posted on July 10, 2021, on bioRxiv. Extrachromosomal elements (ECE) comprise structures such as plasmids, megaplasmids, viruses, etc. which give rise to attributes like antibiotic resistance in bacteria. However, as reported in […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Remdesivir resistant SARS-CoV-2!

bioxone January 6, 2021January 5, 2021

Parnad Basu, Amity University Kolkata Remdesivir (C27H35N6O8P), is a broad-spectrum antiviral medication. It is administered via injection into a vein. Before the completion of clinical trials of the COVID-19 vaccines, remdesivir will be used to fight COVID-19. Now, COVID-19 is always mutating. And it is important to study those mutations to make remdesivir more effective […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy